Research Areas of Special Interest:
- Minimally invasive surgery
- Value-Based Care
- Personalized Cancer Care (molecular and immunologic profiling)
- Microbiome and its role in cancer
- Quality outcomes in cancer surgery
- Physiology of circulating gastrointestinal regulatory peptides
- Radioimmunoassay of peptides in pathophysiological conditions
- Role of cholecystokinin in the control of growth and regulation of the pancreas
- Pathophysiology of an endocrine tumor-peptic ulcer model
- Oncogene expression and amplification in carcinoid tumors
- Molecular and physiological regulation of small bowel absorption
- Molecular profiling of gastrointestinal malignancies
- Immunotherapy of gastrointestinal malignancies
Research and Clinical Trial Cooperative Groups:
- 1999-2001 Invited Participant/Co-Investigator, American College of Surgeons Oncology Group
- Lymph node mapping and sentinel lymph node biopsy for stage I, II, III colon
Cancer
- Co-Founder, International Consortium of Research (INCORE) of the Theodor-Billroth-Academy (TBA)
- Member, United States Military Cancer Institute
Research Grants:
- 1988-1989 Amelioration of traumatic pancreatitis by CCK antagonist.
- OHSE research award-Yale University. $10,000, PI – AJ Bilchik M.D.
- 1989-1990 Bacterial and specific contribution to the mortality of post traumatic pancreatitis in a guinea pig model.
- OHSE research award-Yale University. $9,500, PI – AJ Bilchik M.D
- 1990-1991 Oncogene expression in mastomys carcinoid tumors.
- OHSE research fund award-Yale University. $10,000, PI – AJ Bilchik M.D
- 1991-1997 Surgery and intestinal absorption.
- NIH DK39870-05. (Co-investigator) $600,000, PI – MJ Zinner
- 1997 Early diagnosis and treatment of pancreatic cancer.
- SPORE institutional grant (Collaborator)
- 1998 Molecular Detection of Colon Cancer with a Multiple Marker PCR Assay.
- 1998-1999 Rogavin-Davidow Foundation $75,000
- 1998-1999 Polyvalent Vaccine: Phase III Trial in Stage IV Melanoma
- NIH/NCI 5 P-01 CA29605-18 $878,746, PI – DL Morton M.D.
- 1998-1999 New Approaches to Surgical Oncology
NIH/NCI 5 P01 CA 29605-18 $2,218,374, PI – DL Morton M.D.
- 1999 Rod Fasone Fund $15,000
- 1999-2000 Rogavin-Davidow Foundation $75,000
- 1999-2000 Surgery, Immunology and Immunology of Human Cancer
- NIH/NCI 5 P01 CA12582-28 $3,810,835, PI – DL Morton, M.D.
- 1999-2000 Unrestricted research grant – Rita Medical Incorporated $50,000
- 2000 Rod Fasone Fund $10,000
- 2000-2003 Ultrastaging of Early Colon Cancer Using Lymphatic Mapping and Sentinel Node Analysis $150,000, PI – AJ Bilchik M.D. Ph.D.
- 2000-2006 Ultrastaging of Early Colon Cancer Using Lymphatic Mapping and Sentinel Node Analysis
- NIH/NCI 1 R01 CA90848-01 $2,631,076, PI – AJ Bilchik M.D. Ph.D.
- 2000-2005 Lymph node mapping and sentinel lymph node biopsy for stage I, II, III colon
cancer. American College of Surgeons Oncology Group Grant (submitted)
Collaborator / Co-Investigator – AJ Bilchik M.D. Ph.D.
- 2000-2001 Carbohydrate Antigens As Targets for Vaccine Immunotherapy in Colon Cancer NIH/NCI KO8 Grant (submitted), PI – AJ Bilchik M.D. Ph.D.
- 2000-2001 Carbohydrate Antigens As Targets for Vaccine Immunotherapy in Colon Cancer American Cancer Society Beginning Investigators Grant (submitted), PI – AJ Bilchik M.D. Ph.D.
- 2000-2001 Rogavin-Davidow Foundation $75,000
- 2001 Polyvalent Vaccine: Phase III Trial in Stage IV Colon Cancer, PI – AJ Bilchik, M.D., Ph.D.
- 2001 Rod Fasone Fund $15,000
- 2001 George Hoag Foundation $35,000
- 2001-2002 Rogavin-Davidow Foundation $75,000
- 2002 SPORE in Pancreas Cancer, Co-Investigator – AJ Bilchik M.D. Ph.D., PI – T Adrian, Ph.D.
- 2002 William Randolph Hearst Foundation $500,000
- 2002-2003 Davidow Charitable Fund $75,000
- 2003-2004 Davidow Charitable Fund $75,000
- 2004-2005 Davidow Charitable Fund $75,000
- 2004-2006 Davidow Charitable Fund $75,000
- 2009-2012 William Randolph Hearst Foundation $150,000
- 2008-2013 Ultrastaging of Early Colon Cancer. NIH/NCI 2RO1 CA90848-05A2 $2,638,184.
- PI – AJ Bilchik M.D.Ph.D. FUNDED
- 2010-2014 Molecular Profiling of Stage II Colon Cancer: US Military Cancer Institute Clinical Trials Group GI-02 $3,555,125 PI AJ Bilchik M.D.Ph.D. Submitted DOD
- 2016 Immunoprofiling and Immunotherapy in Colon Cancer PO1 $17,000,000 PI AJ Bilchik M.D.Ph.D. Submitted NCI
